Urinary Neopterin in Patients with Ovarian Cancer
Urinary neopterin, an indicator of systemic immune activation, is increased in most patients with epithelial ovarian carcinoma (EOC) and is an independent prognostic indicator. The data on prognostic significance of neopterin in EOC have been collected before the advent of paclitaxel that has change...
Main Authors: | Melichar Bohuslav, Krcmová Lenka, Kalabova Hana, Svobodova Iveta, Dragounova Emanuela, Vesely Pavel, Hyspler Radomír, Solichova Dagmar, Urbanek Lubor |
---|---|
Format: | Article |
Language: | English |
Published: |
De Gruyter
2006-11-01
|
Series: | Pteridines |
Subjects: | |
Online Access: | https://doi.org/10.1515/pteridines.2006.17.4.145 |
Similar Items
-
Urinary Neopterin in Patients Treated with Gefitinib
by: Kalabova Hana, et al.
Published: (2007-02-01) -
Serial Urinary Neopterin Measurements Reflect the Disease Course in Patients with Epithelial Ovarian Carcinoma Treated with Paclitaxel/Platinum Chemotherapy
by: Melichar Bohuslav, et al.
Published: (2007-02-01) -
Gastrointestinal Permeability - a Parameter of Possible Prognostic Importance in Metastatic Colorectal Carcinoma
by: Melichar Bohuslav, et al.
Published: (2008-02-01) -
Urinary neopterin concentrations during radiotherapy for gynecological cancer
by: Trivedi Sachin Vipin, et al.
Published: (2014-04-01) -
Urinary Neopterin in Patients with upper Gastrointestinal, Biliary and Pancreatic Carcinomas
by: Melichar Bohuslav, et al.
Published: (2006-02-01)